The Lancet Regional Health - Southeast Asia (May 2024)

Population-level cancer screening and cancer care in Bhutan, 2020–2023: a review

  • Thinley Dorji,
  • Sangay Wangmo,
  • Sonam Dargay,
  • Namkha Dorji,
  • Yeshey Dorjey,
  • Birendra Pradhan,
  • Dechen Pema,
  • Choney Dema,
  • Jamyang Choden,
  • Tandin Dorji,
  • Mimi Lhamu Mynak,
  • Pempa,
  • Kinga Jamphel

Journal volume & issue
Vol. 24
p. 100370

Abstract

Read online

Summary: Screening of cancers is an important intervention in reducing the incidence and mortality related to cancers. Bhutan is one small country that is witnessing an increasing incidence and mortality related to cancers. The government implemented a time-bound population-level screening for gastric, cervical and breast cancers from 2020 to 2023 with an overall coverage of 91.2% of the eligible population. Among 370,225 individuals screened for H pylori, 32.4% tested positive; among 53,182 who underwent upper gastrointestinal endoscopy and biopsy, 255 (0.07%) had gastric cancer. Among 10,749 tested for HPV DNA, 9.3% were positive; among 9887 evaluated with colposcopy and biopsy, 154 (0.13%) had cervical cancer. For breast cancer screening, 72,283 underwent clinical breast examination, 845 mammography and cancer was detected in 73 (0.10%) individuals. In this article, we review how Bhutan implemented a population-level cancer screening programme with on boarding of multiple stakeholders and the participation of people across all districts.

Keywords